ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
Source:
Nasdaq GlobeNewswire
/
11 Mar 2024 07:00:00 America/New_York
N/A
Share on,